These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
4042 related items for PubMed ID: 6332614
1. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells. Dippold WG, Knuth A, Meyer zum Büschenfelde KH. Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614 [Abstract] [Full Text] [Related]
2. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. Dippold WG, Knuth A, Meyer zum Büschenfelde KH. Cancer Res; 1984 Feb; 44(2):806-10. PubMed ID: 6362854 [Abstract] [Full Text] [Related]
3. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ. Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024 [Abstract] [Full Text] [Related]
4. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. Harel W, Shau H, Hadley CG, Morgan AC, Reisfeld RA, Cheresh DA, Mitchell MS. Cancer Res; 1990 Oct 01; 50(19):6311-5. PubMed ID: 2400994 [Abstract] [Full Text] [Related]
5. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3. Werkmeister JA, Triglia T, Mackay IR, Dowling JP, Varigos GA, Morstyn G, Burns GF. Cancer Res; 1987 Jan 01; 47(1):225-30. PubMed ID: 3791209 [Abstract] [Full Text] [Related]
6. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy. Ravindranath MH, Morton DL, Irie RF. Cancer Res; 1989 Jul 15; 49(14):3891-7. PubMed ID: 2472199 [Abstract] [Full Text] [Related]
12. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Kageshita T, Nakamura T, Yamada M, Kuriya N, Arao T, Ferrone S. Cancer Res; 1991 Mar 15; 51(6):1726-32. PubMed ID: 1671829 [Abstract] [Full Text] [Related]
14. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient. Abdel-wahab ZA, Gillanders WE, Darrow TL, Seigler HF. Hum Antibodies Hybridomas; 1992 Jan 15; 3(1):32-9. PubMed ID: 1576321 [Abstract] [Full Text] [Related]
15. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. Berd D, Herlyn M, Koprowski H, Mastrangelo MJ. Cancer Res; 1989 Dec 01; 49(23):6840-4. PubMed ID: 2582430 [Abstract] [Full Text] [Related]
16. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells. Welt S, Carswell EA, Vogel CW, Oettgen HF, Old LJ. Clin Immunol Immunopathol; 1987 Nov 01; 45(2):214-29. PubMed ID: 3665201 [Abstract] [Full Text] [Related]
17. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S. Cancer Res; 1994 Jan 15; 54(2):415-21. PubMed ID: 8275478 [Abstract] [Full Text] [Related]